Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and ...
Eli Lilly sues Strive and Empower as FDA lifts tirzepatide shortage status
Eli Lilly sues two compounders over tirzepatide after FDA lifts Zepbound, Mounjaro shortage status in key GLP-1 legal test.
Life Sciences IP Review1d
Eli Lilly sues more US pharmacies as weight loss squeeze increases
Lawsuits against pharmacies in seven states aim to protect its flagship Mounjaro and Zepbound medications | Growing ...
Nasdaq3d
Eli Lilly Sues Pharmacies Over Unauthorized Tirzepatide Compounding
(RTTNews) - Eli Lilly And Co. (LLY) filed lawsuits Tuesday against Strive Pharmacy and Empower Pharmacy, accusing them of unlawfully compounding and selling tirzepatide, the active ingredient in ...
Seeking Alpha3d
Eli Lilly takes actions to stop compounders from making its weight loss med
Eli Lilly (NYSE:LLY) on Tuesday will file lawsuits against two companies that the drug giant is accusing of mass compounding its blockbuster GLP-1/GIP receptor agonist tirzepatide. Tirzepatide is ...
NBC 10 Philadelphia4d
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
Eli Lilly is suing two pharmacies for compounding ... Administration's ban on the practice and luring people away from Lilly's medicines. In lawsuits filed Tuesday in Delaware and New Jersey ...